TreeWAS – Variant ID: rs1727884

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
I25 Chronic ischaemic heart disease	0.000	0.000	1.000
I20-I25 Ischaemic heart diseases	0.000	0.000	1.000
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.001	0.999
I20 Angina pectoris	0.000	0.001	0.999
I20.0 Unstable angina	0.000	0.001	0.999
I25.2 Old myocardial infarction	0.000	0.005	0.995
I24 Other acute ischaemic heart diseases	0.000	0.006	0.994
I24.8 Other forms of acute ischaemic heart disease	0.000	0.043	0.957
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.047	0.953
I20.9 Angina pectoris, unspecified	0.000	0.107	0.893
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.164	0.836
I23 Certain current complications following acute myocardial infarction	0.000	0.196	0.804
I21 Acute myocardial infarction	0.000	0.204	0.796
I21.9 Acute myocardial infarction, unspecified	0.000	0.235	0.765
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.236	0.764
I25.6 Silent myocardial ischaemia	0.000	0.283	0.717
I25.3 Aneurysm of heart	0.000	0.284	0.716
I24.1 Dressler's syndrome	0.000	0.287	0.712
I22 Subsequent myocardial infarction	0.000	0.303	0.697
I25.4 Coronary artery aneurysm	0.000	0.316	0.684
I25.5 Ischaemic cardiomyopathy	0.000	0.326	0.674
I23.8 Other current complications following acute myocardial infarction	0.000	0.336	0.664
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.345	0.655
I20.8 Other forms of angina pectoris	0.000	0.387	0.613
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.404	0.596
I22.8 Subsequent myocardial infarction of other sites	0.000	0.407	0.593
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.408	0.592
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.411	0.589
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.422	0.578
Z95.1 Presence of aortocoronary bypass graft	0.000	0.423	0.577
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.423	0.576
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.423	0.576
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.423	0.576
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.423	0.576
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.423	0.576
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.423	0.576
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.423	0.576
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.429	0.571
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.435	0.565
Z95.4 Presence of other heart-valve replacement	0.000	0.510	0.490
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.513	0.487
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.522	0.478
Z95.3 Presence of xenogenic heart valve	0.000	0.527	0.472
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.532	0.468
Z95.2 Presence of prosthetic heart valve	0.000	0.590	0.410
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.637	0.363
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.649	0.351
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.650	0.350
I20.1 Angina pectoris with documented spasm	0.001	0.697	0.302
Z95.0 Presence of cardiac pacemaker	0.000	0.719	0.281
I21.4 Acute subendocardial myocardial infarction	0.000	0.805	0.195
R14 Flatulence and related conditions	0.000	0.984	0.016
T51.0 Ethanol	0.010	0.990	0.000
J39.2 Other diseases of pharynx	0.000	0.992	0.008
H11.3 Conjunctival haemorrhage	0.000	0.993	0.007
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.000	0.993	0.007
H11.0 Pterygium	0.000	0.993	0.007
H11 Other disorders of conjunctiva	0.000	0.994	0.006
T51 Toxic effect of alcohol	0.006	0.994	0.000
H11.1 Conjunctival degenerations and deposits	0.000	0.995	0.005
M89.8 Other specified disorders of bone	0.005	0.995	0.000
M89.0 Algoneurodystrophy	0.005	0.995	0.000
M89 Other disorders of bone	0.005	0.995	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.995	0.005
T51.9 Alcohol, unspecified	0.005	0.995	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.005	0.995	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.995	0.005
H11.2 Conjunctival scars	0.000	0.995	0.005
M89.9 Disorder of bone, unspecified	0.005	0.995	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.005	0.995	0.000
M89.03 Algoneurodystrophy (Forearm)	0.005	0.995	0.000
M89.84 Other specified disorders of bone (Hand)	0.005	0.995	0.000
T51.8 Other alcohols	0.004	0.995	0.000
T51.3 Fusel oil	0.004	0.995	0.000
T51.2 2-Propanol	0.004	0.995	0.000
T51.1 Methanol	0.004	0.995	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.004	0.996	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.000	0.996	0.004
M89.04 Algoneurodystrophy (Hand)	0.004	0.996	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.004	0.996	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.996	0.004
H83.0 Labyrinthitis	0.000	0.996	0.004
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.996	0.004
M89.3 Hypertrophy of bone	0.004	0.996	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.004	0.996	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.004	0.996	0.000
M89.5 Osteolysis	0.004	0.996	0.000
M89.08 Algoneurodystrophy (Other)	0.004	0.996	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.004	0.996	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.004	0.996	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.004	0.996	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.004	0.996	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.004	0.996	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.004	0.996	0.000
M89.83 Other specified disorders of bone (Forearm)	0.004	0.996	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.004	0.996	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.004	0.996	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.004	0.996	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.004	0.996	0.000
E11.9 Without complications	0.000	0.996	0.004
M89.6 Osteopathy after poliomyelitis	0.004	0.996	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.004	0.996	0.000
M89.2 Other disorders of bone development and growth	0.004	0.996	0.000
M89.1 Epiphyseal arrest	0.004	0.996	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.996	0.004
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.004	0.996	0.000
E10.9 Without complications	0.000	0.996	0.004
E10.2 With renal complications	0.000	0.996	0.004
M89.88 Other specified disorders of bone (Other)	0.004	0.996	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.004	0.996	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.004	0.996	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.004	0.996	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.004	0.996	0.000
O14.9 Preeclampsia, unspecified	0.004	0.996	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.996	0.004
M89.37 Hypertrophy of bone (Ankle and foot)	0.004	0.996	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.004	0.996	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.003	0.996	0.000
E10.5 With peripheral circulatory complications	0.000	0.996	0.004
Z13.6 Special screening examination for cardiovascular disorders	0.004	0.996	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.996	0.004
M89.98 Disorder of bone, unspecified (Other)	0.003	0.997	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.003	0.997	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.003	0.997	0.000
M89.38 Hypertrophy of bone (Other)	0.003	0.997	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.003	0.997	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.003	0.997	0.000
M89.34 Hypertrophy of bone (Hand)	0.003	0.997	0.000
M89.33 Hypertrophy of bone (Forearm)	0.003	0.997	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.003	0.997	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.003	0.997	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.003	0.997	0.000
E10.1 With ketoacidosis	0.000	0.997	0.003
M89.59 Osteolysis (Site unspecified)	0.003	0.997	0.000
M89.58 Osteolysis (Other)	0.003	0.997	0.000
M89.57 Osteolysis (Ankle and foot)	0.003	0.997	0.000
M89.56 Osteolysis (Lower leg)	0.003	0.997	0.000
M89.54 Osteolysis (Hand)	0.003	0.997	0.000
M89.53 Osteolysis (Forearm)	0.003	0.997	0.000
M89.52 Osteolysis (Upper arm)	0.003	0.997	0.000
M89.51 Osteolysis (Shoulder region)	0.003	0.997	0.000
M89.50 Osteolysis (Multiple sites)	0.003	0.997	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.003	0.997	0.000
O14.1 Severe preeclampsia	0.003	0.997	0.000
M89.19 Epiphyseal arrest (Site unspecified)	0.003	0.997	0.000
M89.18 Epiphyseal arrest (Other)	0.003	0.997	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.003	0.997	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.003	0.997	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.003	0.997	0.000
M89.14 Epiphyseal arrest (Hand)	0.003	0.997	0.000
M89.13 Epiphyseal arrest (Forearm)	0.003	0.997	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.003	0.997	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.003	0.997	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.003	0.997	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.003	0.997	0.000
M89.28 Other disorders of bone development and growth (Other)	0.003	0.997	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.003	0.997	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.003	0.997	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.003	0.997	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.003	0.997	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.003	0.997	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.003	0.997	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.003	0.997	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.003	0.997	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.003	0.997	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.003	0.997	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.003	0.997	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.003	0.997	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.003	0.997	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.003	0.997	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.003	0.997	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.003	0.997	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.003	0.997	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.003	0.997	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.003	0.997	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.003	0.997	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.003	0.997	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.003	0.997	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.003	0.997	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.003	0.997	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.003	0.997	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.003	0.997	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.003	0.997	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.003	0.997	0.000
L81.4 Other melanin hyperpigmentation	0.000	0.997	0.003
Z72.1 Alcohol use	0.000	0.997	0.003
I42.0 Dilated cardiomyopathy	0.003	0.997	0.000
J39 Other diseases of upper respiratory tract	0.000	0.997	0.003
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
O14.0 Moderate preeclampsia	0.003	0.997	0.000
S80.8 Other superficial injuries of lower leg	0.003	0.997	0.000
H10-H13 Disorders of conjunctiva	0.000	0.997	0.003
E10.0 With coma	0.000	0.997	0.003
M19.0 Primary arthrosis of other joints	0.000	0.997	0.003
E10.7 With multiple complications	0.000	0.997	0.003
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.997	0.003
H53.2 Diplopia	0.003	0.997	0.000
I42.9 Cardiomyopathy, unspecified	0.003	0.997	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.997	0.003
O14.2 HELLP syndrome	0.002	0.997	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.997	0.003
E10.8 With unspecified complications	0.000	0.997	0.002
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.002	0.998	0.000
E10.4 With neurological complications	0.000	0.998	0.002
J39.9 Disease of upper respiratory tract, unspecified	0.000	0.998	0.002
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.998	0.002
J39.1 Other abscess of pharynx	0.000	0.998	0.002
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.998	0.002
H10 Conjunctivitis	0.000	0.998	0.002
D84.9 Immunodeficiency, unspecified	0.002	0.998	0.000
E10.6 With other specified complications	0.000	0.998	0.002
H83 Other diseases of inner ear	0.000	0.998	0.002
I42 Cardiomyopathy	0.002	0.998	0.000
M79.89 Other specified soft tissue disorders (Site unspecified)	0.000	0.998	0.002
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.998	0.002
H10.9 Conjunctivitis, unspecified	0.000	0.998	0.002
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
M19.08 Primary arthrosis of other joints (Other)	0.000	0.998	0.002
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.998	0.002
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.002
T88.5 Other complications of anaesthesia	0.002	0.998	0.000
C02.9 Tongue, unspecified	0.002	0.998	0.000
C02.1 Border of tongue	0.002	0.998	0.000
H02.8 Other specified disorders of eyelid	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
E10.3 With ophthalmic complications	0.000	0.998	0.002
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.998	0.002
I42.2 Other hypertrophic cardiomyopathy	0.002	0.998	0.000
D84 Other immunodeficiencies	0.002	0.998	0.000
I83 Varicose veins of lower extremities	0.000	0.998	0.002
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
H10.8 Other conjunctivitis	0.000	0.998	0.002
H10.5 Blepharoconjunctivitis	0.000	0.998	0.002
H10.3 Acute conjunctivitis, unspecified	0.000	0.998	0.002
H10.2 Other acute conjunctivitis	0.000	0.998	0.002
H10.1 Acute atopic conjunctivitis	0.000	0.998	0.002
H10.0 Mucopurulent conjunctivitis	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
K26.4 Chronic or unspecified with haemorrhage	0.002	0.998	0.000
N41.0 Acute prostatitis	0.002	0.998	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.998	0.002
H83.9 Disease of inner ear, unspecified	0.000	0.998	0.002
H83.8 Other specified diseases of inner ear	0.000	0.998	0.002
H83.3 Noise effects on inner ear	0.000	0.998	0.002
H83.2 Labyrinthine dysfunction	0.000	0.998	0.002
H83.1 Labyrinthine fistula	0.000	0.998	0.002
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.000	0.998	0.002
H13.3 Ocular pemphigoid	0.000	0.998	0.002
H13.2 Conjunctivitis in other diseases classified elsewhere	0.000	0.998	0.002
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H13.0 Filarial infection of conjunctiva	0.000	0.998	0.002
I42.7 Cardiomyopathy due to drugs and other external agents	0.002	0.998	0.000
I42.5 Other restrictive cardiomyopathy	0.002	0.998	0.000
I42.4 Endocardial fibroelastosis	0.002	0.998	0.000
I42.3 Endomyocardial (eosinophilic) disease	0.002	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
D61.9 Aplastic anaemia, unspecified	0.002	0.998	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.002	0.998	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
I42.6 Alcoholic cardiomyopathy	0.002	0.998	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.000	0.998	0.002
J17.3 Pneumonia in parasitic diseases	0.002	0.998	0.000
D05.1 Intraductal carcinoma in situ	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.002	0.998	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.002	0.998	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.002	0.998	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.002	0.998	0.000
I05.0 Mitral stenosis	0.000	0.998	0.002
C02 Malignant neoplasm of other and unspecified parts of tongue	0.002	0.998	0.000
G41.0 Grand mal status epilepticus	0.002	0.998	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.998	0.002
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
J46 Status asthmaticus	0.002	0.998	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
D84.8 Other specified immunodeficiencies	0.002	0.998	0.000
D84.1 Defects in the complement system	0.002	0.998	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.002	0.998	0.000
I84.2 Internal haemorrhoids without complication	0.002	0.998	0.000
J17.2 Pneumonia in mycoses	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
H10.4 Chronic conjunctivitis	0.000	0.998	0.001
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
D89.3 Immune reconstitution syndrome	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.002	0.998	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.002	0.998	0.000
F33.9 Recurrent depressive disorder, unspecified	0.000	0.998	0.002
D86 Sarcoidosis	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.998	0.002
D80 Immunodeficiency with predominantly antibody defects	0.002	0.998	0.000
S92.50 Fracture of other toe (closed)	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.001	0.998	0.000
I05.9 Mitral valve disease, unspecified	0.000	0.998	0.002
N02.9 Unspecified	0.002	0.998	0.000
N95.2 Postmenopausal atrophic vaginitis	0.000	0.998	0.002
C02.8 Overlapping lesion of tongue	0.001	0.998	0.000
C02.4 Lingual tonsil	0.001	0.998	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.001	0.998	0.000
C02.2 Ventral surface of tongue	0.001	0.998	0.000
C02.0 Dorsal surface of tongue	0.001	0.998	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.002	0.998	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.998	0.000
I05 Rheumatic mitral valve diseases	0.000	0.998	0.002
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.001	0.998	0.000
L81 Other disorders of pigmentation	0.000	0.998	0.002
T65 Toxic effect of other and unspecified substances	0.001	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.001	0.998	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.001	0.998	0.000
T60 Toxic effect of pesticides	0.001	0.998	0.000
T57 Toxic effect of other inorganic substances	0.001	0.998	0.000
T54 Toxic effect of corrosive substances	0.001	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.001	0.998	0.000
T52 Toxic effect of organic solvents	0.001	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.001	0.998	0.000
T55 Toxic effect of soaps and detergents	0.001	0.998	0.000
N81.6 Rectocele	0.000	0.998	0.002
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.002	0.998	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.001	0.998	0.000
D83 Common variable immunodeficiency	0.001	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.001	0.998	0.000
D81 Combined immunodeficiencies	0.001	0.998	0.000
G41.9 Status epilepticus, unspecified	0.001	0.998	0.000
J00 Acute nasopharyngitis [common cold]	0.000	0.998	0.001
S82.40 Fracture of fibula alone (closed)	0.001	0.999	0.000
B00.5 Herpesviral ocular disease	0.001	0.999	0.000
T59 Toxic effect of other gases, fumes and vapours	0.001	0.999	0.000
M86-M90 Other osteopathies	0.001	0.999	0.000
G00.9 Bacterial meningitis, unspecified	0.001	0.999	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.000	0.999	0.001
K31.9 Disease of stomach and duodenum, unspecified	0.001	0.999	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
O16 Unspecified maternal hypertension	0.001	0.999	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.999	0.001
E11.1 With ketoacidosis	0.000	0.999	0.001
L81.9 Disorder of pigmentation, unspecified	0.000	0.999	0.001
T59.9 Gases, fumes and vapours, unspecified	0.001	0.999	0.000
U81.0 Vancomycin resistant agent	0.001	0.999	0.000
C16.0 Cardia	0.000	0.999	0.001
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.999	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.001	0.999	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.001	0.999	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.001	0.999	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.001	0.999	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.001	0.999	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.001	0.999	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.001	0.999	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.999	0.001
T63 Toxic effect of contact with venomous animals	0.001	0.999	0.000
T56 Toxic effect of metals	0.001	0.999	0.000
B37.8 Candidiasis of other sites	0.001	0.999	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.999	0.001
G06.2 Extradural and subdural abscess, unspecified	0.001	0.999	0.000
D25.9 Leiomyoma of uterus, unspecified	0.001	0.999	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
G00 Bacterial meningitis, not elsewhere classified	0.001	0.999	0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
M84.03 Malunion of fracture (Forearm)	0.001	0.999	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.001	0.999	0.000
I05.8 Other mitral valve diseases	0.000	0.999	0.001
I84.4 External haemorrhoids with other complications	0.001	0.999	0.000
T52.9 Organic solvent, unspecified	0.001	0.999	0.000
T52.8 Other organic solvents	0.001	0.999	0.000
T52.4 Ketones	0.001	0.999	0.000
T52.3 Glycols	0.001	0.999	0.000
T52.2 Homologues of benzene	0.001	0.999	0.000
T52.1 Benzene	0.001	0.999	0.000
T52.0 Petroleum products	0.001	0.999	0.000
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.001	0.999	0.000
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.001	0.999	0.000
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.001	0.999	0.000
T53.5 Chlorofluorocarbons	0.001	0.999	0.000
T53.4 Dichloromethane	0.001	0.999	0.000
T53.3 Tetrachloroethylene	0.001	0.999	0.000
T53.2 Trichloroethylene	0.001	0.999	0.000
T53.1 Chloroform	0.001	0.999	0.000
T53.0 Carbon tetrachloride	0.001	0.999	0.000
T54.9 Corrosive substance, unspecified	0.001	0.999	0.000
T54.3 Corrosive alkalis and alklali-like substances	0.001	0.999	0.000
T54.2 Corrosive acids and acid-like substances	0.001	0.999	0.000
T54.1 Other corrosive organic compounds	0.001	0.999	0.000
T54.0 Phenol and phenol homologues	0.001	0.999	0.000
T57.9 Inorganic substance, unspecified	0.001	0.999	0.000
T57.8 Other specified inorganic substances	0.001	0.999	0.000
T57.3 Hydrogen cyanide	0.001	0.999	0.000
T57.2 Manganese and its compounds	0.001	0.999	0.000
T57.1 Phosphorus and its compounds	0.001	0.999	0.000
T57.0 Arsenic and its compounds	0.001	0.999	0.000
T60.9 Pesticide, unspecified	0.001	0.999	0.000
T60.8 Other pesticides	0.001	0.999	0.000
T60.4 Rodenticides	0.001	0.999	0.000
T60.3 Herbicides and fungicides	0.001	0.999	0.000
T60.2 Other insecticides	0.001	0.999	0.000
T60.1 Halogenated insecticides	0.001	0.999	0.000
T60.0 Organophosphate and carbamate insecticides	0.001	0.999	0.000
T61.9 Toxic effect of unspecified seafood	0.001	0.999	0.000
T61.8 Toxic effect of other seafoods	0.001	0.999	0.000
T61.2 Other fish and shellfish poisoning	0.001	0.999	0.000
T61.1 Scombroid fish poisoning	0.001	0.999	0.000
T61.0 Ciguatera fish poisoning	0.001	0.999	0.000
T62.9 Noxious substance eaten as food, unspecified	0.001	0.999	0.000
T62.8 Other specified noxious substances eaten as food	0.001	0.999	0.000
T62.2 Other ingested (parts of) plant(s)	0.001	0.999	0.000
T62.1 Ingested berries	0.001	0.999	0.000
T62.0 Ingested mushrooms	0.001	0.999	0.000
T65.9 Toxic effect of unspecified substance	0.001	0.999	0.000
T65.8 Toxic effect of other specified substances	0.001	0.999	0.000
T65.6 Paints and dyes, not elsewhere classified	0.001	0.999	0.000
T65.5 Nitroglycerin and other nitric acids and esters	0.001	0.999	0.000
T65.4 Carbon disulphide	0.001	0.999	0.000
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.001	0.999	0.000
T65.2 Tobacco and nicotine	0.001	0.999	0.000
T65.1 Strychnine and its salts	0.001	0.999	0.000
T65.0 Cyanides	0.001	0.999	0.000
T78.3 Angioneurotic oedema	0.000	0.999	0.001
T58 Toxic effect of carbon monoxide	0.001	0.999	0.000
L81.7 Pigmented purpuric dermatosis	0.000	0.999	0.001
L81.6 Other disorders of diminished melanin formation	0.000	0.999	0.001
L81.5 Leukoderma, not elsewhere classified	0.000	0.999	0.001
L81.3 Cafe au lait spots	0.000	0.999	0.001
L81.1 Chloasma	0.000	0.999	0.001
L81.0 Postinflammatory hyperpigmentation	0.000	0.999	0.001
S92.0 Fracture of calcaneus	0.001	0.999	0.000
O15 Eclampsia	0.001	0.999	0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.001	0.999	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.001	0.999	0.000
S92.51 Fracture of other toe (open)	0.001	0.999	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.001	0.999	0.000
D81.9 Combined immunodeficiency, unspecified	0.001	0.999	0.000
D81.8 Other combined immunodeficiencies	0.001	0.999	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.999	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.999	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.999	0.000
D81.4 Nezelof's syndrome	0.001	0.999	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.999	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.999	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.999	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.001	0.999	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.001	0.999	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.001	0.999	0.000
D82.2 Immunodeficiency with short-limbed stature	0.001	0.999	0.000
D82.1 Di George's syndrome	0.001	0.999	0.000
D82.0 Wiskott-Aldrich syndrome	0.001	0.999	0.000
D83.9 Common variable immunodeficiency, unspecified	0.001	0.999	0.000
D83.8 Other common variable immunodeficiencies	0.001	0.999	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.001	0.999	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.001	0.999	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.001	0.999	0.000
I77.8 Other specified disorders of arteries and arterioles	0.000	0.999	0.001
L29.0 Pruritus ani	0.000	0.999	0.001
S92.5 Fracture of other toe	0.001	0.999	0.000
T93.0 Sequelae of open wound of lower limb	0.001	0.999	0.000
J17 Pneumonia in diseases classified elsewhere	0.001	0.999	0.000
M87.85 Other osteonecrosis (Pelvic region and thigh)	0.001	0.999	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.999	0.001
J17.1 Pneumonia in viral diseases classified elsewhere	0.001	0.999	0.000
L81.8 Other specified disorders of pigmentation	0.000	0.999	0.001
T59.7 Carbon dioxide	0.001	0.999	0.000
T59.6 Hydrogen sulphide	0.001	0.999	0.000
T59.5 Fluorine gas and hydrogen fluoride	0.001	0.999	0.000
T59.4 Chlorine gas	0.001	0.999	0.000
T59.3 Lachrymogenic gas	0.001	0.999	0.000
T59.2 Formaldehyde	0.001	0.999	0.000
T59.1 Sulphur dioxide	0.001	0.999	0.000
T59.0 Nitrogen oxides	0.001	0.999	0.000
E11.8 With unspecified complications	0.000	0.999	0.001
G02.0 Meningitis in viral diseases classified elsewhere	0.001	0.999	0.000
G03.9 Meningitis, unspecified	0.001	0.999	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.001	0.999	0.000
G04.1 Tropical spastic paraplegia	0.001	0.999	0.000
G04.0 Acute disseminated encephalitis	0.001	0.999	0.000
H36.0 Diabetic retinopathy	0.000	0.999	0.001
I05.2 Mitral stenosis with insufficiency	0.000	0.999	0.001
M87.8 Other osteonecrosis	0.001	0.999	0.000
L50.9 Urticaria, unspecified	0.001	0.999	0.000
L81.2 Freckles	0.000	0.999	0.001
T56.9 Metal, unspecified	0.001	0.999	0.000
T56.7 Beryllium and its compounds	0.001	0.999	0.000
T56.6 Tin and its compounds	0.001	0.999	0.000
T56.5 Zinc and its compounds	0.001	0.999	0.000
T56.4 Copper and its compounds	0.001	0.999	0.000
T56.3 Cadmium and its compounds	0.001	0.999	0.000
T56.2 Chromium and its compounds	0.001	0.999	0.000
T56.1 Mercury and its compounds	0.001	0.999	0.000
T56.0 Lead and its compounds	0.001	0.999	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.001	0.999	0.000
T63.8 Toxic effect of contact with other venomous animals	0.001	0.999	0.000
T63.6 Toxic effect of contact with other marine animals	0.001	0.999	0.000
T63.5 Toxic effect of contact with fish	0.001	0.999	0.000
T63.3 Venom of spider	0.001	0.999	0.000
T63.2 Venom of scorpion	0.001	0.999	0.000
T63.1 Venom of other reptiles	0.001	0.999	0.000
T63.0 Snake venom	0.001	0.999	0.000
F33 Recurrent depressive disorder	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations